Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Thor Asmussen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2017
Extent and computed tomography appearance of early radiation induced lung injury for non-small cell lung cancerUffe Bernchou, Rasmus Lübeck Christiansen, Jon Thor Asmussen, et al.
Cancers|April 12, 2022
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain MetastasisBirgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, et al.
Cancers|August 6, 2020
Multiple Myeloma Associated Bone DiseaseStine Rasch, Thomas Lund, Jon Thor Asmussen, et al.
Scientific Reports|September 28, 2023
Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative studyMohammad Naghavi-Behzad, Oke Gerke, Annette Raskov Kodahl, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT imagesChristian Rønn Hansen, Rasmus Lübeck Christiansen, Ebbe Laugaard Lorenzen, et al.
BMC Medical Genomics|November 22, 2024
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort studyKarin Holmskov Hansen, Maria Bibi Lyng, Annette Raskov Kodahl, et al.
Molecular Imaging and Biology|March 7, 2023
Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary HyperparathyroidismSys Vestergaard, Oke Gerke, Mette Bay, et al.
Cancers|August 27, 2021
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast CancerMohammad Naghavi-Behzad, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, et al.
EJNMMI Research|September 23, 2021
Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical studyMarianne Vogsen, Jeanette Dupont Jensen, Oke Gerke, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
FDG-PET/CT can rule out malignancy in patients with vocal cord palsyAnders Thomassen, Anne Lerberg Nielsen, Jeppe Kiilerich Lauridsen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2017
Extent and computed tomography appearance of early radiation induced lung injury for non-small cell lung cancerUffe Bernchou, Rasmus Lübeck Christiansen, Jon Thor Asmussen, et al.
Cancers|April 12, 2022
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain MetastasisBirgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, et al.
Cancers|August 6, 2020
Multiple Myeloma Associated Bone DiseaseStine Rasch, Thomas Lund, Jon Thor Asmussen, et al.
Scientific Reports|September 28, 2023
Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative studyMohammad Naghavi-Behzad, Oke Gerke, Annette Raskov Kodahl, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT imagesChristian Rønn Hansen, Rasmus Lübeck Christiansen, Ebbe Laugaard Lorenzen, et al.
BMC Medical Genomics|November 22, 2024
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort studyKarin Holmskov Hansen, Maria Bibi Lyng, Annette Raskov Kodahl, et al.
Molecular Imaging and Biology|March 7, 2023
Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary HyperparathyroidismSys Vestergaard, Oke Gerke, Mette Bay, et al.
Cancers|August 27, 2021
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast CancerMohammad Naghavi-Behzad, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, et al.
EJNMMI Research|September 23, 2021
Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical studyMarianne Vogsen, Jeanette Dupont Jensen, Oke Gerke, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
FDG-PET/CT can rule out malignancy in patients with vocal cord palsyAnders Thomassen, Anne Lerberg Nielsen, Jeppe Kiilerich Lauridsen, et al.
Pageof 2